Skip to main navigation Skip to search Skip to main content

Primary target volume delineation for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas

Ling-Long Tang, Cheng-Long Huang, Shao-Jun Lin, Quynh-Thu Le, Brian O'Sullivan, Sue S Yom, Shao Hui Huang, Annie W Chan, Nancy Lee, Jian-Ji Pan, Michael Benedict A Mejia, Yong Chan Ahn, Kenneth C W Wong, Lachlan McDowell, Ester Orlandi, Jeppe Friborg, Yu-Pei Chen, Koichi Yasuda, Takeshi Kodaira, Alexander C WhitleyAnn D King, Gregorius Ben Prajogi, Ezra Hahn, Jin-Ching Lin, Naomi Kiyota, Victor Lee, Peng-Jie Ji, Ying Hitchcock, Frank Hoebers, Pierre Blanchard, Sung Ho Moon, Wan Zamaniah Wan Ishak, Kevin J Harrington, Kun-Yu Yang, A Dimitrios Colevas, Anna Lee, Chao-Su Hu, David Rosenthal, Farzan Siddiqui, Johannes Albertus Langendijk, Jin-Yi Lang, Jun-Lin Yi, Liang-Fang Shen, Ji-Bin Li, Li-Zhi Liu, Anne W M Lee, Hai-Qiang Mai, Ming-Kai Yang, Ying Sun, Melvin L K Chua, Jun Ma*

*Corresponding author for this work
8 Citations (Scopus)

Abstract

The Chinese Society for Therapeutic Radiology Oncology, the Chinese Anti-Cancer Association, the Chinese Society of Clinical Oncology, Head and Neck Cancer International Group, the European Society for Radiotherapy and Oncology, and the American Society for Radiation Oncology jointly developed evidence-based guidelines and a contouring atlas for primary target volume delineation for radiotherapy in nasopharyngeal carcinoma. The guidelines systematically address three crucial challenges: margin design of clinical target volumes; target volume delineation after induction chemotherapy; and low-risk clinical target volume delineation based on local stepwise extension patterns. Based on a comprehensive systematic review and critical appraisal by an international multidisciplinary panel of 50 nasopharyngeal carcinoma specialists from 17 countries and regions, these guidelines are in keeping with advances in nasopharyngeal carcinoma diagnosis and treatment, embodying contemporary treatment concepts, and elaborating on the differences in practice. These guidelines aim to support global clinical practice in radiotherapy target volume delineation, substantially enhancing homogeneity and reducing variability in nasopharyngeal carcinoma target delineation.

Original languageEnglish
JournalThe Lancet Oncology
Volume26
Issue number9
Pages (from-to)e477-e487
ISSN1470-2045
DOIs
Publication statusPublished - Sept 2025

Keywords

  • Humans
  • Nasopharyngeal Carcinoma/radiotherapy
  • Nasopharyngeal Neoplasms/radiotherapy
  • Radiotherapy Planning, Computer-Assisted/standards
  • Radiation Oncology/standards

Fingerprint

Dive into the research topics of 'Primary target volume delineation for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas'. Together they form a unique fingerprint.

Cite this